HEADER TRANSFERASE 20-AUG-08 3E8N TITLE X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 TITLE 2 (MEK1) COMPLEXED WITH A POTENT INHIBITOR RDEA119 AND MGATP COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE KINASE 1, MAPKK 1, ERK ACTIVATOR KINASE 1, COMPND 5 MAPK/ERK KINASE 1, MEK1; COMPND 6 EC: 2.7.12.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: MEK1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET24B KEYWDS PROTEIN KINASE-LIGAND-MGATP COMPLEX, RDEA119, RDEA-119, MEK1, MEK1- KEYWDS 2 RDEA119 COMPLEX, ACETYLATION, ATP-BINDING, DISEASE MUTATION, KINASE, KEYWDS 3 NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 4 TRANSFERASE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR S.YAN,Z.M.WANG REVDAT 3 30-AUG-23 3E8N 1 REMARK SEQADV LINK REVDAT 2 15-SEP-09 3E8N 1 JRNL REVDAT 1 01-SEP-09 3E8N 0 JRNL AUTH C.IVERSON,G.LARSON,C.LAI,L.T.YEH,C.DADSON,P.WEINGARTEN, JRNL AUTH 2 T.APPLEBY,T.VO,A.MADERNA,J.M.VERNIER,R.HAMATAKE,J.N.MINER, JRNL AUTH 3 B.QUART JRNL TITL RDEA119/BAY 869766: A POTENT, SELECTIVE, ALLOSTERIC JRNL TITL 2 INHIBITOR OF MEK1/2 FOR THE TREATMENT OF CANCER. JRNL REF CANCER RES. V. 69 6839 2009 JRNL REFN ISSN 0008-5472 JRNL PMID 19706763 JRNL DOI 10.1158/0008-5472.CAN-09-0679 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 16933 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1688 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2275 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 65 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.17300 REMARK 3 B22 (A**2) : 0.17300 REMARK 3 B33 (A**2) : -0.34600 REMARK 3 B12 (A**2) : -0.12100 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3E8N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049013. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 150 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC BLUE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17113 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.12500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1S9J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM HEPES, 150 MM NH4H2PO4, 0.5 MM REMARK 280 EDTA, 2 MM TCEP, PH 7.8, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.51867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.25933 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 86.51867 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 43.25933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MEK1 IS A MONOMER IN SOLUTION AND IN THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 41.13050 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 71.24012 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 223 REMARK 465 GLY A 276 REMARK 465 CYS A 277 REMARK 465 GLN A 278 REMARK 465 VAL A 279 REMARK 465 GLU A 280 REMARK 465 GLY A 281 REMARK 465 ASP A 282 REMARK 465 ALA A 283 REMARK 465 ALA A 284 REMARK 465 GLU A 285 REMARK 465 THR A 286 REMARK 465 PRO A 287 REMARK 465 PRO A 288 REMARK 465 ARG A 289 REMARK 465 PRO A 290 REMARK 465 ARG A 291 REMARK 465 THR A 292 REMARK 465 PRO A 293 REMARK 465 GLY A 294 REMARK 465 ARG A 295 REMARK 465 PRO A 296 REMARK 465 LEU A 297 REMARK 465 SER A 298 REMARK 465 SER A 299 REMARK 465 TYR A 300 REMARK 465 GLY A 301 REMARK 465 MET A 302 REMARK 465 ASP A 303 REMARK 465 SER A 304 REMARK 465 ARG A 305 REMARK 465 GLN A 383 REMARK 465 PRO A 384 REMARK 465 SER A 385 REMARK 465 THR A 386 REMARK 465 PRO A 387 REMARK 465 THR A 388 REMARK 465 HIS A 389 REMARK 465 ALA A 390 REMARK 465 ALA A 391 REMARK 465 GLY A 392 REMARK 465 VAL A 393 REMARK 465 LEU A 394 REMARK 465 GLU A 395 REMARK 465 HIS A 396 REMARK 465 HIS A 397 REMARK 465 HIS A 398 REMARK 465 HIS A 399 REMARK 465 HIS A 400 REMARK 465 HIS A 401 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 262 C - N - CA ANGL. DEV. = 9.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 135 -105.97 -108.98 REMARK 500 GLU A 138 144.34 -175.26 REMARK 500 ARG A 189 -13.10 83.67 REMARK 500 ASP A 190 53.11 -148.43 REMARK 500 SER A 241 -151.33 -158.36 REMARK 500 LEU A 342 34.55 -91.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 500 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 195 OD1 REMARK 620 2 ASP A 208 OD1 103.2 REMARK 620 3 ATP A 600 O2A 166.5 75.3 REMARK 620 4 ATP A 600 O1B 94.5 150.5 82.0 REMARK 620 5 HOH A1002 O 92.9 82.9 73.6 72.7 REMARK 620 6 HOH A1003 O 115.2 83.7 78.1 109.9 151.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VRA A1001 DBREF 3E8N A 62 393 UNP Q02750 MP2K1_HUMAN 62 393 SEQADV 3E8N MET A 61 UNP Q02750 EXPRESSION TAG SEQADV 3E8N LEU A 394 UNP Q02750 EXPRESSION TAG SEQADV 3E8N GLU A 395 UNP Q02750 EXPRESSION TAG SEQADV 3E8N HIS A 396 UNP Q02750 EXPRESSION TAG SEQADV 3E8N HIS A 397 UNP Q02750 EXPRESSION TAG SEQADV 3E8N HIS A 398 UNP Q02750 EXPRESSION TAG SEQADV 3E8N HIS A 399 UNP Q02750 EXPRESSION TAG SEQADV 3E8N HIS A 400 UNP Q02750 EXPRESSION TAG SEQADV 3E8N HIS A 401 UNP Q02750 EXPRESSION TAG SEQRES 1 A 341 MET GLU LEU LYS ASP ASP ASP PHE GLU LYS ILE SER GLU SEQRES 2 A 341 LEU GLY ALA GLY ASN GLY GLY VAL VAL PHE LYS VAL SER SEQRES 3 A 341 HIS LYS PRO SER GLY LEU VAL MET ALA ARG LYS LEU ILE SEQRES 4 A 341 HIS LEU GLU ILE LYS PRO ALA ILE ARG ASN GLN ILE ILE SEQRES 5 A 341 ARG GLU LEU GLN VAL LEU HIS GLU CYS ASN SER PRO TYR SEQRES 6 A 341 ILE VAL GLY PHE TYR GLY ALA PHE TYR SER ASP GLY GLU SEQRES 7 A 341 ILE SER ILE CYS MET GLU HIS MET ASP GLY GLY SER LEU SEQRES 8 A 341 ASP GLN VAL LEU LYS LYS ALA GLY ARG ILE PRO GLU GLN SEQRES 9 A 341 ILE LEU GLY LYS VAL SER ILE ALA VAL ILE LYS GLY LEU SEQRES 10 A 341 THR TYR LEU ARG GLU LYS HIS LYS ILE MET HIS ARG ASP SEQRES 11 A 341 VAL LYS PRO SER ASN ILE LEU VAL ASN SER ARG GLY GLU SEQRES 12 A 341 ILE LYS LEU CYS ASP PHE GLY VAL SER GLY GLN LEU ILE SEQRES 13 A 341 ASP SER MET ALA ASN SER PHE VAL GLY THR ARG SER TYR SEQRES 14 A 341 MET SER PRO GLU ARG LEU GLN GLY THR HIS TYR SER VAL SEQRES 15 A 341 GLN SER ASP ILE TRP SER MET GLY LEU SER LEU VAL GLU SEQRES 16 A 341 MET ALA VAL GLY ARG TYR PRO ILE PRO PRO PRO ASP ALA SEQRES 17 A 341 LYS GLU LEU GLU LEU MET PHE GLY CYS GLN VAL GLU GLY SEQRES 18 A 341 ASP ALA ALA GLU THR PRO PRO ARG PRO ARG THR PRO GLY SEQRES 19 A 341 ARG PRO LEU SER SER TYR GLY MET ASP SER ARG PRO PRO SEQRES 20 A 341 MET ALA ILE PHE GLU LEU LEU ASP TYR ILE VAL ASN GLU SEQRES 21 A 341 PRO PRO PRO LYS LEU PRO SER GLY VAL PHE SER LEU GLU SEQRES 22 A 341 PHE GLN ASP PHE VAL ASN LYS CYS LEU ILE LYS ASN PRO SEQRES 23 A 341 ALA GLU ARG ALA ASP LEU LYS GLN LEU MET VAL HIS ALA SEQRES 24 A 341 PHE ILE LYS ARG SER ASP ALA GLU GLU VAL ASP PHE ALA SEQRES 25 A 341 GLY TRP LEU CYS SER THR ILE GLY LEU ASN GLN PRO SER SEQRES 26 A 341 THR PRO THR HIS ALA ALA GLY VAL LEU GLU HIS HIS HIS SEQRES 27 A 341 HIS HIS HIS HET MG A 500 1 HET ATP A 600 31 HET VRA A1001 31 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM VRA N-{3,4-DIFLUORO-2-[(2-FLUORO-4-IODOPHENYL)AMINO]-6- HETNAM 2 VRA METHOXYPHENYL}-1-[(2S)-2,3- HETNAM 3 VRA DIHYDROXYPROPYL]CYCLOPROPANESULFONAMIDE FORMUL 2 MG MG 2+ FORMUL 3 ATP C10 H16 N5 O13 P3 FORMUL 4 VRA C19 H20 F3 I N2 O5 S FORMUL 5 HOH *65(H2 O) HELIX 1 1 LYS A 64 ASP A 66 5 3 HELIX 2 2 LYS A 104 GLN A 116 1 13 HELIX 3 3 VAL A 117 CYS A 121 5 5 HELIX 4 4 SER A 150 GLY A 159 1 10 HELIX 5 5 PRO A 162 LYS A 185 1 24 HELIX 6 6 LYS A 192 SER A 194 5 3 HELIX 7 7 SER A 212 MET A 219 1 8 HELIX 8 8 SER A 231 GLY A 237 1 7 HELIX 9 9 VAL A 242 GLY A 259 1 18 HELIX 10 10 ASP A 267 PHE A 275 1 9 HELIX 11 11 ALA A 309 GLU A 320 1 12 HELIX 12 12 SER A 331 LEU A 342 1 12 HELIX 13 13 ASP A 351 VAL A 357 1 7 HELIX 14 14 HIS A 358 GLU A 367 1 10 HELIX 15 15 ASP A 370 ILE A 379 1 10 SHEET 1 A 5 PHE A 68 ALA A 76 0 SHEET 2 A 5 VAL A 81 HIS A 87 -1 O SER A 86 N GLU A 69 SHEET 3 A 5 VAL A 93 HIS A 100 -1 O LEU A 98 N VAL A 81 SHEET 4 A 5 GLU A 138 GLU A 144 -1 O MET A 143 N ALA A 95 SHEET 5 A 5 PHE A 129 TYR A 134 -1 N PHE A 133 O SER A 140 SHEET 1 B 2 ILE A 196 VAL A 198 0 SHEET 2 B 2 ILE A 204 LEU A 206 -1 O LYS A 205 N LEU A 197 LINK OD1 ASN A 195 MG MG A 500 1555 1555 1.89 LINK OD1 ASP A 208 MG MG A 500 1555 1555 2.05 LINK MG MG A 500 O2A ATP A 600 1555 1555 2.32 LINK MG MG A 500 O1B ATP A 600 1555 1555 2.06 LINK MG MG A 500 O HOH A1002 1555 1555 2.29 LINK MG MG A 500 O HOH A1003 1555 1555 1.98 CISPEP 1 ILE A 263 PRO A 264 0 0.38 SITE 1 AC1 5 ASN A 195 ASP A 208 ATP A 600 HOH A1002 SITE 2 AC1 5 HOH A1003 SITE 1 AC2 24 GLY A 77 ASN A 78 GLY A 80 VAL A 82 SITE 2 AC2 24 ALA A 95 LYS A 97 MET A 143 GLU A 144 SITE 3 AC2 24 MET A 146 SER A 150 GLN A 153 LYS A 192 SITE 4 AC2 24 SER A 194 ASN A 195 LEU A 197 ASP A 208 SITE 5 AC2 24 MG A 500 VRA A1001 HOH A1002 HOH A1003 SITE 6 AC2 24 HOH A1014 HOH A1030 HOH A1044 HOH A1066 SITE 1 AC3 13 GLY A 79 LYS A 97 LEU A 115 VAL A 127 SITE 2 AC3 13 ASP A 190 ASP A 208 PHE A 209 VAL A 211 SITE 3 AC3 13 SER A 212 LEU A 215 ATP A 600 HOH A1002 SITE 4 AC3 13 HOH A1022 CRYST1 82.261 82.261 129.778 90.00 90.00 120.00 P 62 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012156 0.007019 0.000000 0.00000 SCALE2 0.000000 0.014037 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007705 0.00000